970PA phase 1 study of selinexor (S) in combination with paclitaxel (P) and carboplatin (C) in patients (pts) with advanced ovarian (OC) or endometrial cancers (EC)
Makker, V., Boucicaut, N., Cadoo, K.A., Grisham, R., Hyman, D.M., O'Cearbhail, R., Snyder Charen, A., Tew, W., Martin, M., Aghajanian, C.Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx372.041
Date:
September, 2017
File:
PDF, 46 KB
english, 2017
File converter
More search results
More benefits 
